Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH)

Annals of Hematology

Volumn 83, Issue 6, 2004, Pages 349-355

  Bacher, U ^a   Kern, W ^a   Schoch, C ^a   Hiddemann, W ^a   Haferlach, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CLL PL; Cytomorphology; Interphase fluorescence in situ hybridization; Prolymphocytes

Indexed keywords

ADULT; AGED; ARTICLE; CELL COUNT; CELL STRUCTURE; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTE; PROLYMPHOCYTIC LEUKEMIA; STAINING; TRISOMY 12;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COHORT STUDIES; CYTOGENETICS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, PROLYMPHOCYTIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 2542493069     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0869-4     Document Type: Article

References (32)

1. Bennett JM, Gatovsky D, Daniel MT (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 42:567-584
2. Bennett JM (2002) The FAB/MIC/WHO proposals for the classification of the chronic lymphoid leukemias. Rev Clin Exp Hematol 6:330-334
3. Bigoni R, Cuneo A, Roberti MG, Bardi A, Rigolin GM, Piva N, Scapoli G, Spanedda R, Negrini M, Bullrich F, Veronese ML, Croce CM, Castoldi G (1997) Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study. Leukemia 11:1933-1940
4. Buhmann R, Kurzeder C, Rehklau J, Westhaus D, Bursch S, Hiddemann W, Haferlach T, Hallek M, Schoch C (2002) CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukemia cells. Br J Haematol 118:968-975
5. Cano I, Martinez E, Quevedo J, Pinilla J, Martin-Recio A, Rodriguez A, Castaneda A, Lopez R, Perez-Pino T, Hernandez-Navarro F (1996) Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy. Cancer Genet Cytogenet 90:118-124
6. Criel A, Michaux L, De Wolf-Peeters C (1999) The concept of typical and atypical chronic lymphocytic leukemia. Leuk Lymphoma 33:33-45
7. Criel A, Verhoef G, Vlietinck R, Mecucci C, Billiet J, Michaux L, Meeus P, Louwagie A, Van Orshoven A, Van Hoff A, Boogaerts M, Van den Berghe H, De Wolf-Peeters C (1997) Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol 97:383-391
8. D'Arena G, Dell'Olio M, Cascavilla N, Dell'Olio M, Di Renzo N, Perla G, Savino L, Carotenuto M (2001) CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 42:109-114
9. D'Arena G, Dell'Olio M, Pellegrino M, Cascavilla N, Perla G, Savino L, Greco MM (2001) Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density. Leuk Lymphoma 42:649-654
10. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Döhner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916
11. Frater JL, McCarron K, Hammel J, Shapiro JL, Miller ML, Tubbs RR, Pettay J, Hsi ED (2001) Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 116:655-664
12. Geisler CH, Philip P, Christensen E, Hou-Jensen K, Tinggaard Pedersen N, Myhre Jensen O, Thorling K, Andersen E, Birgens HS, Drivsholm A, Ellegaard J, Larsen JK, Plesner T, Brown P, Krah Andersen P, Mork Hansen M (1997) In B-cell chronic lymphocytic leukemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 21:1011-1023
13. Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B (1999) Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood 93:1732-1737
14. Hallek M, Wanders L, Ostwald M, Busch R, Senekowitsch RSS, Schick HD, Kuhn-Hallek I, Emmerich B (1996) Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma 22:439-447
15. Hercher C, Robain M, Davi F, Garand R, Flandrin G, Valensi F, Vandeputte H, Albert A, Maynadie M, Troussard X, Hoerni Simon G, Lespinasse J, Portefaix G, Merle-Beral H (2001) A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms. Leuk Lymphoma 42:981-987
16. Hjalmar V, Kimby E, Matutes E, Sundström C, Wallvik J, Hast R (2000) Atypical lymphocytes in B-cell chronic lymphatic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization. Leuk Lymphoma 37:571-576
17. Hjalmar V, Hast R, Kimby E (2002) Cell surface expression of CD 25, CD 54, and CD 95 on B- and T-cells in chronic lymphocytic leukemia in relation to trisomy 12, atypical morphology and clinical course. Eur J Haematol 68:127-134
18. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumors and hematopoietic and lymphoid tissues. World Health Organization classification of tumours. IARC-Press, Lyon
19. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720-724
20. Lens D, Matutes E, Catovsky D, Coignet LJA (2000) Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia 14:427-430
21. Lens D, Dyer M, Garcia-Marco J, De Schouwer PJJ, Hamoudi R, Jones D, Farahat N, Matutes E (1997) p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol 99:848-857
22. Magnac C, Porcher R, Davi F, Nataf J, Payelle-Brogard B, Tang RP, Oppezzo P, Levy V, Dighiero G (2003) Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL leukemia. 17:133-137
23. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham A, Gillingham R, Hamblin T, Lens D, Swansbury J, Catovsky D (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients Br J Haematol 92:382-388
24. Matutes E, Polliack A (2000) Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol 4:22-47
25. Mauro FR, Gentile M, Mancini F, Giannarelli D, Guarini A, De Propriis MS, Cerretti R, Foa R (2002) Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine and prednisone. Haematologica 87:602-608
26. Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A, Morra E, Keating MJ (2003) Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Blood 97:114-120
27. O'Connor SJM, Su'ut L, Morgan GJ, Jack AS (2000) The relationship between typical and atypical B-CLL. A comparative genomic hybridization-based study. Hematopathology 114:448-458
28. Oscier DG, Gardiner A, Mould S, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA, Orchard JA, Hamblin TJ (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100:1177-1184
29. Oscier DG, Matutes E, Copplestone A, Pickering RM, Chapman R, Gillingham R, Catovsky D, Hamblin TJ (1997) Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 98:934-939
30. Que TH, Garcia Marco J, Ellis J, Matutes E, Brito Babapulle VB, Boyle S, Catovsky D (1993) Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood 82:571-575
31. Shvidel L, Shtalrid M, Bassous L, Bassous L, Klepfish A, Vorst E, Berrebi A (1999) B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma 33:169-179
32. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944-4951